Endothelial marker profiles in cerebral radiation-induced vasculopathy: A comparative immunohistochemical analysis
Mohammad Mohsen Mosleh,Moon-Jun Sohn,Han Seong Kim
DOI: https://doi.org/10.1097/md.0000000000037130
IF: 1.6
2024-02-03
Medicine
Abstract:Radiation vasculopathy, characterized by pathological reorganization of vascular tissue post-radiation exposure, is a significant concern, with radiation-induced cerebral vasculopathy reported in 17% to 93% of cases. [ 1 , 2 ] Factors such as radiation dosage, exposure duration, and tissue type influence outcomes, and diagnosis latency can extend up to 25 years. [ 1 ] Late vascular complications of cranial irradiation encompass diverse manifestations, including cerebrovascular accidents, lacunar lesions, and occlusive diseases. [ 3 ] Recent insights suggest a multifaceted interaction between various brain cell populations leading to progressive neurological damage. [ 4 , 5 ] The vascular endothelium, pivotal in cardiovascular homeostasis, is sensitive to radiation injury. [ 6 ] Following radiation, initial vascular changes compromise the blood-brain barrier, leading to vasogenic edema and a hypoxic brain environment. Subsequent oxidative stress causes endothelial damage, impairing vasomotor response and endothelial structure. Acute phases may display thrombus formation and hemorrhage, while late phases exhibit capillary deterioration, scarring, and fibrosis. [ 7 ] Endothelial dysfunction, resulting from various pathophysiological stimuli, including radiation, promotes an environment prone to inflammation, coagulation, and thrombosis. [ 8–10 ] Following radiation injury to vascular endothelium, a cascade of molecular and cellular events ensue, including endothelial activation either directly through radiation or indirectly via reactive oxygen species (ROS). This cascade leads to inflammation, plaque formation, accelerated atherosclerosis, thrombosis, and fibrosis. Various pathways and markers, such as Chemoattractant protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1), P-selectin, E-selectin, vascular adhesion molecule-1 (VCAM-1), matrix metalloproteinase-9 (MMP-9), and inflammatory and growth factors contribute to immune cell attraction, transmigration, and initiation and protraction of inflammation. [ 9 , 11 , 12 ] Leukocyte adhesion to the endothelium initiates the inflammatory phase of atherogenesis. [ 13 ] The establishment and progression of atherosclerotic lesions involve inflammatory cytokines, vascular smooth muscle transformations, and leukocyte and apoptotic cell accumulation. [ 14 ] Plasminogen activator inhibitor-1 (PAI-1) and Endothelial-to-Mesenchymal Transition further contribute to plaque development, leading to thrombosis. [ 15 ] Neovascularization, a risk factor for plaque instability, can accelerate endothelial lesion progression, increase oxidative stress, and elevate inflammatory cell recruitment. [ 16 ] Addressing long-term side effects post-radiotherapy, especially cerebral vasculopathy, is crucial due to the increasing number of patients with extended lifespans after treatment. This study employs immunohistochemistry (IHC) to explore endothelial expressions of E and P selectins, ICAM-1, VCAM-1, eNOS, PAI-1, and MMP-9 in irradiated and non-radiated patients. This study aimed to identify the specific roles of markers in the pathogenesis of cerebral vascular endothelial injury after radiosurgery and explore the distinct expression patterns of each marker in various pathologies following stereotactic radiosurgery (SRS), guiding potential preventive and therapeutic interventions for mitigating long-term radiation adverse effects.
medicine, general & internal